17160-Pancreatic Cancer-NA-1286

Pancreatic Cancer

PANOVA-3: Pivotal, randomized, open-label study of Tumor Treating Fields (TTFields, 150kHz) concomitant with gemcitabine and nab-paclitaxel for front-line treatment of locally-advanced pancreatic adenocarcinoma (EF-27)

  • Details

ClinicalTrials.gov ID: NCT03377491
Diagnosis Type: NA
USOR Number:

  • Address

1845 W. Orange Grove, Bldg. 2
Tucson, AZ 85704
P: (520) 624-7445

Search by practice name, trial titles, indicators and specific disease types.